Sloan Sheldon
Chief Medical Officer · 15 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 6,500 | $87.52 | $568,880.00 | filing |
| 2026-07-01 | SYRE | Spyre Therapeutics, Inc. | Option exercise | 8,334 | $27.46 | $228,851.64 | filing |
| 2026-07-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 1,834 | $88.34 | $162,015.56 | filing |
| 2026-06-03 | SYRE | Spyre Therapeutics, Inc. | Sale | 8,333 | $75.00 | $624,975.00 | filing |
| 2026-06-03 | SYRE | Spyre Therapeutics, Inc. | Option exercise | 8,333 | $27.46 | $228,824.18 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Option exercise | 78,333 | $27.46 | $2.2M | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 21,306 | $69.53 | $1.5M | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 19,656 | $70.61 | $1.4M | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 12,777 | $72.94 | $931,954.38 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 10,358 | $73.74 | $763,798.92 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 8,777 | $71.56 | $628,082.12 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 5,059 | $74.60 | $377,401.40 | filing |
| 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 400 | $75.37 | $30,148.00 | filing |
| 2026-04-01 | SYRE | Spyre Therapeutics, Inc. | Sale | 7,958 | $50.00 | $397,900.00 | filing |
| 2026-04-01 | SYRE | Spyre Therapeutics, Inc. | Option exercise | 7,958 | $21.66 | $172,370.28 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.